D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.09% |
| 2 | Technology | 10.39% |
| 3 | Financials | 9.94% |
| 4 | Consumer Discretionary | 8.57% |
| 5 | Communication Services | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
PUT
Nabors Industries
NBR
$1.23B
| $276K | ﹤0.01% |
600
-2,400
| -80% | -$891K |
|
3027
Southern Copper
SCCO
$141B
| $276K | ﹤0.01% |
10,755
-7,583
| -41% | -$179K |
|
3028
WD-40
WDFC
$3.1B
| $276K | ﹤0.01% |
+2,555
| New | +$264K |
|
3029
Costco
COST
$415B
| $275K | ﹤0.01% |
1,747
-34,592
| -95% | -$5.24M |
|
3030
Kforce
KFRC
$983M
| $274K | ﹤0.01% |
+13,972
| New | +$269K |
|
|
WRI
3031
DELISTED
Weingarten Realty Investors
WRI
| $274K | ﹤0.01% |
7,309
-80,716
| -92% | -$2.84M |
|
3032
AppFolio
APPF
$5.85B
| $273K | ﹤0.01% |
22,300
-18,529
| -45% | -$236K |
|
|
VOXX
3033
DELISTED
VOXX International Corporation Class A
VOXX
| $272K | ﹤0.01% |
60,865
+19,656
| +48% | +$85.9K |
|
|
LCI
3034
DELISTED
Lannett Company, Inc.
LCI
| $271K | ﹤0.01% |
+3,774
| New | +$400K |
|
|
AHT
3035
Ashford Hospitality Trust
AHT
$21M
| $270K | ﹤0.01% |
+43
| New | +$233K |
|
3036
Amphastar Pharmaceuticals
AMPH
$825M
| $270K | ﹤0.01% |
22,501
-78,974
| -78% | -$931K |
|
|
GOOD
3037
Gladstone Commercial Corp
GOOD
$627M
| $270K | ﹤0.01% |
+16,478
| New | +$243K |
|
3038
Rocky Brands
RCKY
$304M
| $270K | ﹤0.01% |
21,213
+9,114
| +75% | +$104K |
|
3039
PUT
Honeywell
HON
$77.1B
| $269K | ﹤0.01% |
2,671
-48,856
| -95% | -$4.58M |
|
3040
CALL
Wolfspeed
WOLF
$1.2B
| $268K | ﹤0.01% |
+9,200
| New | +$264K |
|
3041
PUT
3M
MMM
$89B
| $267K | ﹤0.01% |
1,914
-87,068
| -98% | -$11.2M |
|
3042
SEI Investments
SEIC
$11.9B
| $267K | ﹤0.01% |
6,192
-20,761
| -77% | -$851K |
|
3043
MYR Group
MYRG
$5.9B
| $266K | ﹤0.01% |
+10,597
| New | +$229K |
|
|
NDRM
3044
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $263K | ﹤0.01% |
18,658
+4,006
| +27% | +$54.1K |
|
|
WW
3045
DELISTED
WW International
WW
| $261K | ﹤0.01% |
17,955
-1,149,233
| -98% | -$15.6M |
|
3046
Enterprise Financial Services Corp
EFSC
$2.41B
| $260K | ﹤0.01% |
9,607
-4,255
| -31% | -$116K |
|
|
JMEI
3047
CALL
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
| $260K | ﹤0.01% |
4,000
| – | – |
|
3048
Addus HomeCare
ADUS
$2.14B
| $259K | ﹤0.01% |
15,053
-37,315
| -71% | -$771K |
|
3049
Central Pacific Financial
CPF
$997M
| $257K | ﹤0.01% |
+11,819
| New | +$241K |
|
3050
National Beverage
FIZZ
$2.87B
| $257K | ﹤0.01% |
+12,132
| New | +$241K |
|
Similar funds
D.E. Shaw & Co's Q1 2016 Portfolio in Review
As of Q1 2016, D.E. Shaw & Co held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
D.E. Shaw & Co withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, D.E. Shaw & Co opened a new position in EQT Corp worth $47.6M.
- D.E. Shaw & Co's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- D.E. Shaw & Co added most to Allergan plc in Q1 2016, an estimated $397M increase.
- D.E. Shaw & Co's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- D.E. Shaw & Co fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- D.E. Shaw & Co's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- D.E. Shaw & Co opened 382 new positions and closed 773 in Q1 2016.
- D.E. Shaw & Co's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.